Aptose Biosciences (TSE:APS – Get Free Report) (NASDAQ:APTO) issued its quarterly earnings results on Tuesday. The biotechnology company reported C($1.96) EPS for the quarter, topping the consensus estimate of C($1.98) by C$0.02, reports.
Aptose Biosciences Trading Up 9.3 %
TSE APS opened at C$2.24 on Friday. Aptose Biosciences has a 12 month low of C$1.85 and a 12 month high of C$13.35. The stock has a 50-day simple moving average of C$2.43 and a 200 day simple moving average of C$3.18. The company has a current ratio of 1.59, a quick ratio of 5.41 and a debt-to-equity ratio of 14.27. The company has a market capitalization of C$35.19 million, a PE ratio of -0.21 and a beta of 1.44.
Aptose Biosciences Company Profile
Further Reading
- Five stocks we like better than Aptose Biosciences
- What Investors Need to Know About Upcoming IPOs
- 3 Value Stocks Too Small For Buffett’s Portfolio
- What is a Dividend King?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What Are Dividends? Buy the Best Dividend Stocks
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.